Association between triglyceride‑glucose index as a marker of insulin resistance and the risk of malignant melanoma: A retrospective study
Jiukang Sun,
No information about this author
Zhihang Han,
No information about this author
Chuanjun Song
No information about this author
et al.
Oncology Letters,
Journal Year:
2025,
Volume and Issue:
29(4)
Published: Feb. 7, 2025
Malignant
melanoma,
a
highly
malignant
tumor
predominantly
found
on
the
skin
surface,
has
exhibited
an
alarming
rise
in
both
incidence
and
mortality
rates
annually
since
2012.
Despite
its
relatively
low
occurrence
among
malignancies,
rate
of
melanoma
remains
disproportionately
high.
The
prognosis
relies
heavily
early
stage
detection,
with
significant
disparity
survival
between
I
IV
patients.
Studies
exploring
insulin
resistance
(IR)
as
potential
risk
factor
for
are
scarce.
present
study
therefore
investigated
association
triglyceride
glucose
(TyG)
index,
indicator
IR,
incidence.
Retrospective
data
from
patients
diagnosed
at
First
Affiliated
Hospital
Nanjing
Medical
University
(Nanjing,
China)
January
2019
2024
were
collected.
Basic
information,
including
age,
sex
body
mass
hematological
test
results,
such
those
fasting
triglycerides
blood
glucose,
analyzed.
Logistic
regression
analysis
receiver
operating
characteristic
(ROC)
curve
employed
to
explore
TyG
index.
A
total
403
participants,
272
melanomas
131
nevi,
included
study.
group
significantly
higher
levels
index
compared
control
(P<0.001).
Univariate
multivariable
logistic
analyses
revealed
independent
(OR,
6.33;
95%
CI,
3.56‑11.27;
P<0.001).
Incidence
increased
across
tertiles
ROC
identified
clinically
acceptable
predictive
cutoff
point
provides
evidence
that
is
melanoma.
findings
underscore
utility
biomarker
diagnosing
suggest
new
avenues
treatment
strategies.
Language: Английский
Spectrum of presentation of intraocular metastases from cutaneous melanoma in the era of immunotherapy and targeted therapies
S. Lemaître,
No information about this author
Anmol Arora,
No information about this author
Gordon Robert Hay
No information about this author
et al.
Eye,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 25, 2025
Language: Английский
Cutaneous melanoma
Nature Reviews Disease Primers,
Journal Year:
2025,
Volume and Issue:
11(1)
Published: April 3, 2025
Language: Английский
Correspondence
Stephan Kühne
No information about this author
Deutsches Ärzteblatt international,
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 17, 2024
Correspondence
Deutsches Ärzteblatt international,
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 17, 2024
Trends in incidence, mortality, and survival of cutaneous malignant melanoma over three decades: a population-based study in Southern Spain
Clinical and Experimental Dermatology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 22, 2024
Abstract
Background
Cutaneous
malignant
melanoma
(CMM)
represents
a
global
public
health
problem.
Epidemiological
studies
about
CMM
trends
tend
to
focus
on
single
indicators
or
lack
information
tumour
characteristics
that
can
help
gain
more
thorough
understanding
of
epidemiology.
Objectives
To
fill
this
gap,
we
studied
in
incidence,
mortality
and
survival
over
three
decades
considered
sex,
age
characteristics.
Methods
Data
were
obtained
for
all
patients
with
new
diagnosis
during
1985–2017
from
the
population-based
cancer
registry
Granada
(Southern
Spain)
deaths
owing
Ministry
Health
Spanish
government.
Incidence,
estimates
according
group,
anatomical
site,
histological
type,
Breslow
index
Clark
level.
Observed
net
calculated
1,
3
5
years
using
Kaplan–Meier
Pohar–Perme
methods,
respectively.
Log-linear
jointpoint
regression
was
used
assess
temporal
age-standardized
rates
incidence
mortality.
Results
Between
1985
2017,
2446
aged
≥
15
newly
diagnosed
CMM.
There
significant
increase
both
males
females
(annual
percentage
change
4.4%
3.7%,
respectively),
mainly
superficial
spreading
nodular
melanomas,
pronounced
among
those
<
1
mm
index.
Mortality
increased,
driven
by
increases
individuals
65
old.
Nodular
had
worst
prognosis,
5-year
62.7%
period
2008–2017
compared
>
90%
other
subtypes.
Overall
improved
78.3%
1985–1997
88.6%
2008–2017,
clear
trend
Conclusions
The
early
stages
Southern
Spain
has
increased
recent
decades.
This
been
accompanied
noticeable
improvements
survival,
especially
younger
groups,
suggesting
potential
effectiveness
prevention
strategies
treatment
regimens.
Language: Английский
Novel Approaches to 3D Skin Cancer Models Usability in Research
Interdisciplinary cancer research,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 1, 2024
Language: Английский
Impact of Patient’s Age and Physician’s Professional Background on the Number Needed to Treat in Malignant Melanoma Detection
Laura Schreieder,
No information about this author
Veronika Zenderowski,
No information about this author
Mark Berneburg
No information about this author
et al.
Cancers,
Journal Year:
2024,
Volume and Issue:
16(23), P. 4014 - 4014
Published: Nov. 29, 2024
With
regard
to
excision
of
pigmented
lesions
for
detection
malignant
melanoma
(MM),
the
number
needed
treat
(NNT)
describes
melanocytic
nevi
that
need
be
biopsied/excised
detect
one
MM.
The
aim
should
a
low
NNT.
Language: Английский